ROCKVILLE, Md. & LONDON----Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced the full presentation of results from BLISS-52, the first of two pivotal Phase 3 trials of BENLYSTA™ in seropositive patients with systemic lupus erythematosus .

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News